Providing high quality, innovative
molecular diagnostic tools and advanced health care information technology solutions.
«At Penn State Hershey, an important cancer research focus is to develop
molecular diagnostic tools that are tailored to individuals using a personalized medicine approach,» said Dr. Daniel A. Notterman, vice dean for research and graduate studies, Penn State College of Medicine and associate vice president for health sciences research, Penn State.
«We suggest that the herbal industry should embrace
molecular diagnostic tools such as DNA barcoding for authenticating herbal products through testing of raw materials used in manufacturing products.
Not exact matches
MaRS client Rna
Diagnostics Inc., a
molecular diagnostics company developing
tools to assist in the management of cancer chemotherapy, today announces that it has appointed Dr. Harry D. Bear to its Clinical Advisory Board.
As the line between laboratory and bedside blurs, the translation of research methodologies into a clinical setting clearly points to a future where those technologies currently driving discovery will also provide robust
tools for
molecular diagnostics.
«Considering that there is currently no clinical screening
tool other than family history, this is a significant advance for development of
molecular diagnostic tests,» she said.
«Considering that there is currently no clinical screening
tool other than family history, this is a significant advance for development of
molecular diagnostic tests,» Iyengar said.
Our data and findings will also support development of more effective
molecular diagnostic tests, as well as improved public health surveillance
tools.»
The Institute of Medicine (IOM) report says that so - called «omics» tests —
diagnostic tools based on
molecular patterns — are highly prone to errors; it recommends they be rigorously validated before being used in clinical trials.
«This rapid, simple, cost - effective and minimally invasive technique could be further developed into a personalized
diagnostic tool that would assess disease status based on an individual's
molecular composition and allow for personalized diagnosis and drug management.
The Broad Institute seeks to describe all the
molecular components of life and their connections; discover the
molecular basis of major human diseases; develop effective new approaches to
diagnostics and therapeutics; and disseminate discoveries,
tools, methods, and data openly to the entire scientific community.
The identification of new biomarkers and of the
molecular pathway of the DM1 may lead to possible therapeutic applications and the development of new
diagnostic tools for DM1.
The research group headed by Mats Nilsson, professor of Biochemistry /
molecular diagnostics at Stockholm University, has since the beginning of year 2000 developed new
diagnostic tools based on analysis of genetic information (DNA and RNA) in cells and in body fluids.
SEATTLE, Jan. 16, 2018 (GLOBE NEWSWIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science
tools for translational research and
molecular diagnostic products, today announced that Thomas Bailey has been appointed chief financial officer, effective January 16, 2018.
SEATTLE, Jan. 19, 2018 (GLOBE NEWSWIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science
tools for translational research and
molecular diagnostic products, today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Thomas Bailey, NanoString's new Chief Financial Officer.
SEATTLE, Feb. 05, 2018 (GLOBE NEWSWIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science
tools for translational research and
molecular diagnostic products, today announced the publication of a landmark study in which Danish researchers used the Prosigna ® Breast Cancer Assay risk of recurrence (ROR) score to accurately predict rates of 10 - year distant recurrence (DR) of cancer in a comprehensive and population - based cohort including all postmenopausal women in Denmark with early - stage hormone receptor (HR)- positive, Her - 2 negative breast cancer who received 5 years of adjuvant endocrine therapy according to nationwide guidelines between 2000 and 2003.
Our ultimate goals in this activity include (1) a better understanding of the
molecular mechanisms governing cellular processes and especially those involved in certain kinds of diseases such as cancer and (2) the development of computational
tools that can be used for
diagnostic / prognostic purposes based on genomic data.
The students have undergone a comprehensive education in life science emphasising cutting - edge methods in bioinformatic analysis of big data, high throughput techniques of
molecular biology as well as how to translate biological findings into
diagnostic tools and novel treatments.
Why It Matters: One of the most powerful
diagnostic and analytical
tools in chemistry and materials science, MAS NMR spectroscopy provides high spectral resolution and detailed structural information about a sample on an atomistic or
molecular level and allows scientists to follow changes over time regardless of whether the sample is a solid or a liquid or a mixture of solid, liquid, and gas phases.
Invivoscribe Technologies Inc. is a privately held biotechnology company dedicated to improving the quality of healthcare worldwide by providing high quality, reliable, cutting - edge reagents, tests, and bioinformatics
tools to advance the fields of personalized
molecular diagnostics ® and personalized
molecular medicine.
SEATTLE, March 07, 2018 (GLOBE NEWSWIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science
tools for translational research and
molecular diagnostic products, today reported financial results for the fourth quarter and year ended December 31, 2017.
SEATTLE, April 09, 2018 (GLOBE NEWSWIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science
tools for translational research and
molecular diagnostic products, today announced that the Company will release first quarter 2018 financial results after the close of trading on
These
tools enable life scientists to analyse components of living cells at the
molecular level which is essential in a wide range of fields including drug discovery,
diagnostics, and basic research.
SEATTLE, March 06, 2018 (GLOBE NEWSWIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science
tools for translational research and
molecular diagnostic products, today announced that the company's management is scheduled to present at the 38th Annual Cowen Healthcare
SEATTLE, March 06, 2018 (GLOBE NEWSWIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science
tools for translational research and
molecular diagnostic products, today announced that the company's management is scheduled to present at the 38th Annual Cowen Healthcare Conference in Boston.
Committed to improving the quality of healthcare worldwide by providing high quality, reliable, cutting - edge
tools for
molecular diagnostic and personalized
molecular medicine.
Invivoscribe is committed to improving the quality of healthcare worldwide, providing high quality, reliable, cutting - edge
tools for
molecular diagnostics and personalized
molecular medicine
His research focuses on
molecular analytics with the aim to improve
diagnostic tools for infectious diseases and cancer.
My team studies new ways to control Australian horticultural pests by applying fundamental knowledge in insect chemical ecology (e.g. to develop new insect attractants),
molecular biology (e.g. for new insect
diagnostic tools), and insect ecology (e.g. insect biocontrol agents).
This session will focus on skeletal dysplasias as a model for rare genetic diseases, highlighting
tools for collecting natural history data and healthcare needs data; key
diagnostic clinical and
molecular features; and management, including novel emerging disease - modifying treatments based on better understanding of
molecular pathogenesis.
It is his mission to provide high quality, reliable, cutting - edge reagents, tests, and bioinformatic
tools to advance the fields of personalized
molecular diagnostics ® and personalized
molecular medicine ®.
Dr. Maria Esteve - Gasent, an assistant professor in the CVM's Department of Veterinary Pathobiology (VTPB), and doctoral student Joseph Modarelli, in collaboration with the Texas A&M Veterinary Medical
Diagnostic Laboratory (TVMDL), developed the
tool, the TickPath LayerPlex, using a
molecular technique that allows the researchers to determine if causative agents from tick - borne diseases are present in a dog.
Canuto, V.M., and A. Battaglia, 1985: Turbulence in
molecular clouds: A new
diagnostic tool to probe their origin.
In the field of life sciences, he has successfully litigated major cases involving recombinant DNA, monoclonal antibodies, fusion proteins, siRNAs, small molecule compounds, drug delivery,
molecular diagnostics, research
tool patents, and medical devices.
New York, NY About Blog GenomeWeb is an online news organization serving the global community of scientists, technology professionals, and executives who use and develop the latest advanced
tools in
molecular biology research and
molecular diagnostics.